Effect of colchicine in the subcorneal pustular dermatosis type of IgA pemphigus.
IgA pemphigus of the subcorneal pustular dermatosis (SPD) type is characterized by subcorneal acantholysis and by an abundance of neutrophils, making colchicine a reasonable pharmacologic option for treatment. We attempted to determine the efficacy of colchicine in the treatment of SPD-type IgA pemphigus. Two patients with SPD-type IgA pemphigus were treated with colchicine 1.5 mg/day as monotherapy. A sustained clinical response was achieved within 2 to 3 weeks of therapy. Relapses were noted each time colchicine was stopped. Colchicine should be considered in the treatment of SPD-type IgA pemphigus.